Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Breaking News: Markets Meta Platforms Inc Economy
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Finance Economy Meta Platforms Inc
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Eisai Co Ltd Science Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Social issues Health & Science
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Breaking News: Markets JD/Com Inc Economy
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Breaking News: Business Business News Science
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Biotech and Pharmaceuticals Alzheimer's disease Biotechnology
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Oil and Gas Investment Strategy Biogen Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Breaking News: Business Eisai Co Ltd Business News
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Economy Match Group Inc Pearson PLC
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Coronavirus Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Business News Breaking News: Business Epidemics
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Politics Congress U/S/ Economy
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Business Biogen Inc Health care industry
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Ionis Pharmaceuticals Inc Breaking News: Business Science
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Biotechnology Biotech and Pharmaceuticals Eisai Co Ltd
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Biotechnology Biotech and Pharmaceuticals Breaking News: Business
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Biotechnology Biotech and Pharmaceuticals Business News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Business News Eisai Co Ltd Breaking News: Business
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Biotech and Pharmaceuticals Coronavirus Biotechnology
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Health & Science Policy Disease outbreaks
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Redfin Corp Economy Breaking News: Markets
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Breaking News: Business Business News Eisai Co Ltd
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags Breaking News: Business Business News Eisai Co Ltd
From CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
Tags Tripadvisor Inc Biogen Inc Taiwan Semiconductor Manufacturing Co Ltd
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags Breaking News: Business Eisai Co Ltd Business News
From CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
Tags Biogen Inc Business Toro Co
From CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Tags Business Biogen Inc Toro Co
From CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
Tags Finance DoorDash Inc CrowdStrike Holdings Inc
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.